In the current study, we analyzed the clinical characteristics and prognosis of 80 ALK rearranged lung cancer patients who underwent radical surgical treatment in our department between 2016 and 2019 with 3031 ALK‐negative lung adenocarcinoma patients as controls. This evidence concerns the gene ALK and lung adenocarcinoma.